Ardsley Advisory Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$1.66M | – | 111 |
|
|
2024
Q2 | $1.66M | Sell |
250,000
-25,000
| -9% | -$166K | 0.24% | 66 |
|
|
2024
Q1 | $2.8M | Sell |
275,000
-66,000
| -19% | -$672K | 0.4% | 64 |
|
|
2023
Q4 | $3.82M | Sell |
341,000
-651,050
| -66% | -$7.3M | 0.59% | 35 |
|
|
2023
Q3 | $2.58M | Sell |
992,050
-50,000
| -5% | -$130K | 0.58% | 43 |
|
|
2023
Q2 | $3.68M | Sell |
1,042,050
-405,200
| -28% | -$1.43M | 0.62% | 40 |
|
|
2023
Q1 | $6.11M | Buy |
1,447,250
+742,500
| +105% | +$3.13M | 1.34% | 27 |
|
|
2022
Q4 | $11.6M | Sell |
704,750
-223,200
| -24% | -$3.67M | 2.4% | 9 |
|
|
2022
Q3 | $11.9M | Sell |
927,950
-411,050
| -31% | -$5.25M | 2.65% | 9 |
|
|
2022
Q2 | $15.7M | Sell |
1,339,000
-14,000
| -1% | -$164K | 2.58% | 5 |
|
|
2022
Q1 | $8.24M | Buy |
1,353,000
+299,000
| +28% | +$1.82M | 1.37% | 23 |
|
|
2021
Q4 | $9.66M | Buy |
1,054,000
+26,500
| +3% | +$243K | 1.84% | 17 |
|
|
2021
Q3 | $11.7M | Buy |
1,027,500
+726,000
| +241% | +$8.28M | 1.79% | 12 |
|
|
2021
Q2 | $2.99M | Buy |
+301,500
| New | +$2.99M | 0.35% | 45 |
|